title: The current status of sheep pox disease.
abstract: Sheep are the moving banks of shepherds and their economic contribution in terms of meat, wool and skin/hide is immense. Various infectious diseases jeopardize the optimum productivity; among which sheep pox is more important as the disease restricts the export of sheep and their products besides other economic losses. Although, clinical signs are indicative of the disease but a laboratory confirmation is necessary for unequivocal diagnosis and studying epidemiology. The causative agent, sheep pox virus (SPV), is antigenically and genetically closely related to goat pox virus (GPV) and lumpy skin disease virus (LSDV), the other members of the genus capripox virus. In some countries, SPV and GPV are cross infective to small ruminants posing problem in diagnosis and epidemiology. However, recent studies have showed that the viruses are phylogenetically distinct and can be differentiated by molecular tools. Prophylaxis using attenuated vaccines is the choice of control measure as the immunity is long lasting. Detailed information on isolation, identification, pathology, epidemiology, diagnosis and prophylaxis would not only help in updating the knowledge of scientific fraternity but will be useful to the policy makers in order to formulate appropriate measures for control and eradication of the disease. This synthesis is to present an up-to-date review of the disease and its control to provide the reader with an overview of the problem.
authors.affiliation: Division of Virology, Indian Veterinary Research Institute, Mukteswar, Nainital (District), Uttaranchal 263 138, India. bhanupraaakash@yahoo.co.in
authors.forename: V
authors.initials: V
authors.lastname: Bhanuprakash
authors.forename: B K
authors.initials: BK
authors.lastname: Indrani
authors.forename: M
authors.initials: M
authors.lastname: Hosamani
authors.forename: R K
authors.initials: RK
authors.lastname: Singh
mesh_terms: D000818:Animals; D018151:Capripoxvirus / Q000254:growth & development*; D005260:Female; D008297:Male; D011213:Poxviridae Infections / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000821:virology*; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated / Q000276:immunology / Q000627:therapeutic use; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use
chemical_list: D014613:Vaccines, Attenuated; D014765:Viral Vaccines